Latest news
Regentis Biomaterials Advances GelrinC Toward FDA Approval and European Expansion - citybuzz -citybuzz - · Sat, 08 Aug 2026 00:18:51 GMTRegentis Biomaterials Advances GelrinC as Potential First-in-Class Cartilage Repair Treatment - citybuzz -citybuzz - · Tue, 04 Aug 2026 00:29:26 GMTRegentis Biomaterials Advances GelrinC as Potential First-in-Class Cartilage Repair Therapy - citybuzz -citybuzz - · Sat, 01 Aug 2026 00:36:57 GMTRegentis Biomaterials (NYSE American: RGNT) Builds Commercial and Regulatory Momentum as GelrinC Advances - BenzingaBenzinga · Wed, 29 Jul 2026 16:44:11 GMT